CytomX Therapeutics
CTMX
2,12 €
Share price
0.81%
Change (1 day)
78.09%
Change (1 year)
Categories
CytomX Therapeutics (CTMX) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : €62.35 Million
According to CytomX Therapeutics 's latest financial reports the company's total liabilities are €62.35 Million. A company’s total liabilities is the sum of all current and non-current debts and obligations.
CytomX Therapeutics - Total liabilities on balance sheet (from 2014 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | €0.11 B | -48.43% |
| 2023-12-31 | €0.22 B | -30.23% |
| 2022-12-31 | €0.32 B | 7.68% |
| 2021-12-31 | €0.30 B | 0.73% |
| 2020-12-31 | €0.29 B | 15.01% |
| 2019-12-31 | €0.25 B | -9.17% |
| 2018-12-31 | €0.28 B | 4.4% |
| 2017-12-31 | €0.27 B | 138.15% |
| 2016-12-31 | €0.11 B | 76.28% |
| 2015-12-31 | €65.06 M | -47.8% |
| 2014-12-31 | €0.12 B | 194.46% |
| 2013-12-31 | €42.33 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | €19.62 M | -68.52% | 🇺🇸 USA |